Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1861 to 1872 of 1876 entries
Sorted by: Best Match Show Resources per page
AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications.

BMC infectious diseases

Notter J, Seiffert SN, Zimmermann-Kogadeeva M, Bösch A, Wenger R, Strahm C, Frischknecht M, Livermore DM, Babouee Flury B.
PMID: 34991516
BMC Infect Dis. 2022 Jan 06;22(1):33. doi: 10.1186/s12879-021-07000-y.

BACKGROUND: Data on antimicrobial resistance mechanisms are scanty for Cedecea spp., with very variable antibiotic resistance patterns documented. Here we report the first in vivo resistance evolution of a C. davisae clinical isolate in a patient with a complex...

Cite
Notter J, Seiffert SN, Zimmermann-Kogadeeva M, et al. AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications. BMC Infect Dis. 2022;22(1):33doi: 10.1186/s12879-021-07000-y.
Notter, J., Seiffert, S. N., Zimmermann-Kogadeeva, M., Bösch, A., Wenger, R., Strahm, C., Frischknecht, M., Livermore, D. M., & Babouee Flury, B. (2022). AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications. BMC infectious diseases, 22(1), 33. https://doi.org/10.1186/s12879-021-07000-y
Notter, Julia, et al. "AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications." BMC infectious diseases vol. 22,1 (2022): 33. doi: https://doi.org/10.1186/s12879-021-07000-y
Notter J, Seiffert SN, Zimmermann-Kogadeeva M, Bösch A, Wenger R, Strahm C, Frischknecht M, Livermore DM, Babouee Flury B. AmpC hyperproduction in a Cedecea davisae implant-associated bone infection during treatment: a case report and therapeutic implications. BMC Infect Dis. 2022 Jan 06;22(1):33. doi: 10.1186/s12879-021-07000-y. PMID: 34991516; PMCID: PMC8734214.
Copy Download .nbib Format: NLM
Two cases of delayed hypersensitivity to clavulanic acid proven by patch tests.

Contact dermatitis

Calvão J, Batista R, Gonçalo M.
PMID: 33837970
Contact Dermatitis. 2021 Sep;85(3):370-372. doi: 10.1111/cod.13859. Epub 2021 May 10.

No abstract available.

Cite
Calvão J, Batista R, Gonçalo M. Two cases of delayed hypersensitivity to clavulanic acid proven by patch tests. Contact Dermatitis. 2021;85(3):370-372doi: 10.1111/cod.13859.
Calvão, J., Batista, R., & Gonçalo, M. (2021). Two cases of delayed hypersensitivity to clavulanic acid proven by patch tests. Contact dermatitis, 85(3), 370-372. https://doi.org/10.1111/cod.13859
Calvão, Joana, et al. "Two cases of delayed hypersensitivity to clavulanic acid proven by patch tests." Contact dermatitis vol. 85,3 (2021): 370-372. doi: https://doi.org/10.1111/cod.13859
Calvão J, Batista R, Gonçalo M. Two cases of delayed hypersensitivity to clavulanic acid proven by patch tests. Contact Dermatitis. 2021 Sep;85(3):370-372. doi: 10.1111/cod.13859. Epub 2021 May 10. PMID: 33837970.
Copy Download .nbib Format: NLM
Residual β-lactam antibiotics and ecotoxicity to Vibrio fischeri, Daphnia magna of pharmaceutical wastewater in the treatment process.

Journal of hazardous materials

Hu Y, Lei D, Wu D, Xia J, Zhou W, Cui C.
PMID: 34896711
J Hazard Mater. 2021 Nov 22;425:127840. doi: 10.1016/j.jhazmat.2021.127840. Epub 2021 Nov 22.

The discharge of pharmaceutical wastewater introduces numerous pollutants into the environment, and their pollution level reduction has aroused extensive concern. This study investigated the variation in residual antibiotics and ecotoxicity to two nutritional-level model organisms in the pharmaceutical wastewater...

Cite
Hu Y, Lei D, Wu D, et al. Residual β-lactam antibiotics and ecotoxicity to Vibrio fischeri, Daphnia magna of pharmaceutical wastewater in the treatment process. J Hazard Mater. 2021;425:127840doi: 10.1016/j.jhazmat.2021.127840.
Hu, Y., Lei, D., Wu, D., Xia, J., Zhou, W., & Cui, C. (2021). Residual β-lactam antibiotics and ecotoxicity to Vibrio fischeri, Daphnia magna of pharmaceutical wastewater in the treatment process. Journal of hazardous materials, 425127840. https://doi.org/10.1016/j.jhazmat.2021.127840
Hu, Yaru, et al. "Residual β-lactam antibiotics and ecotoxicity to Vibrio fischeri, Daphnia magna of pharmaceutical wastewater in the treatment process." Journal of hazardous materials vol. 425 (2021): 127840. doi: https://doi.org/10.1016/j.jhazmat.2021.127840
Hu Y, Lei D, Wu D, Xia J, Zhou W, Cui C. Residual β-lactam antibiotics and ecotoxicity to Vibrio fischeri, Daphnia magna of pharmaceutical wastewater in the treatment process. J Hazard Mater. 2021 Nov 22;425:127840. doi: 10.1016/j.jhazmat.2021.127840. Epub 2021 Nov 22. PMID: 34896711.
Copy Download .nbib Format: NLM
Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study.

Sexually transmitted diseases

McNeil CJ, Tan A, Powell JA, Pontius A, Lewis A, Myler N, Schwebke JR.
PMID: 34475360
Sex Transm Dis. 2021 Aug 31; doi: 10.1097/OLQ.0000000000001555. Epub 2021 Aug 31.

BACKGROUND: Research suggests that Gardnerella vaginalis (GV) is the keystone pathogen in bacterial vaginosis (BV). Knowledge gaps exist regarding the role of GV eradication in the development of BV. This study was designed to test the hypothesis that vaginal...

Cite
McNeil CJ, Tan A, Powell JA, et al. Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study. Sex Transm Dis. 2021;doi: 10.1097/OLQ.0000000000001555.
McNeil, C. J., Tan, A., Powell, J. A., Pontius, A., Lewis, A., Myler, N., & Schwebke, J. R. (2021). Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study. Sexually transmitted diseases, . https://doi.org/10.1097/OLQ.0000000000001555
McNeil, Candice J, et al. "Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study." Sexually transmitted diseases vol. (2021). doi: https://doi.org/10.1097/OLQ.0000000000001555
McNeil CJ, Tan A, Powell JA, Pontius A, Lewis A, Myler N, Schwebke JR. Evaluating the efficacy of eradicating Gardnerella vaginalis (GV) vaginal colonization with amoxicillin; a randomized, double-blind, phase 2 study. Sex Transm Dis. 2021 Aug 31; doi: 10.1097/OLQ.0000000000001555. Epub 2021 Aug 31. PMID: 34475360.
Copy Download .nbib Format: NLM
Cost-Effectiveness Analysis of the Prophylactic Use of Ertapenem for the Prevention of Surgical Site Infections after Elective Colorectal Surgery.

Antibiotics (Basel, Switzerland)

Vicentini C, Gianino MM, Corradi A, Marengo N, Bordino V, Corcione S, De Rosa FG, Fattore G, Zotti CM.
PMID: 33806477
Antibiotics (Basel). 2021 Mar 04;10(3). doi: 10.3390/antibiotics10030259.

Standard surgical antimicrobial prophylaxis (SAP) regimens are less effective in preventing surgical site infections (SSIs) due to rising antimicrobial resistance (AMR) rates, particularly for patients undergoing colorectal surgery. This study aimed to evaluate whether ertapenem should be a preferred...

Cite
Vicentini C, Gianino MM, Corradi A, et al. Cost-Effectiveness Analysis of the Prophylactic Use of Ertapenem for the Prevention of Surgical Site Infections after Elective Colorectal Surgery. Antibiotics (Basel). 2021;10(3)doi: 10.3390/antibiotics10030259.
Vicentini, C., Gianino, M. M., Corradi, A., Marengo, N., Bordino, V., Corcione, S., De Rosa, F. G., Fattore, G., & Zotti, C. M. (2021). Cost-Effectiveness Analysis of the Prophylactic Use of Ertapenem for the Prevention of Surgical Site Infections after Elective Colorectal Surgery. Antibiotics (Basel, Switzerland), 10(3), . https://doi.org/10.3390/antibiotics10030259
Vicentini, Costanza, et al. "Cost-Effectiveness Analysis of the Prophylactic Use of Ertapenem for the Prevention of Surgical Site Infections after Elective Colorectal Surgery." Antibiotics (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/antibiotics10030259
Vicentini C, Gianino MM, Corradi A, Marengo N, Bordino V, Corcione S, De Rosa FG, Fattore G, Zotti CM. Cost-Effectiveness Analysis of the Prophylactic Use of Ertapenem for the Prevention of Surgical Site Infections after Elective Colorectal Surgery. Antibiotics (Basel). 2021 Mar 04;10(3). doi: 10.3390/antibiotics10030259. PMID: 33806477; PMCID: PMC7999678.
Copy Download .nbib Format: NLM
Betalactam hypersensitivity: The importance of delabelling in primary care.

British journal of clinical pharmacology

Ben Fadhel N, Aroua F, Chadli Z, Ben Romdhane H, Chaabane A, Sahtout M, Boughattas NA, Ben Fredj N, Aouam K.
PMID: 33899257
Br J Clin Pharmacol. 2021 Dec;87(12):4619-4624. doi: 10.1111/bcp.14879. Epub 2021 May 14.

PATIENTS AND METHODS: An allergy work-up was performed on adult patients with a history of a penicillin allergy seen by primary medical care in Monastir (Tunisia) between July 2016 and February 2018. Patients with negative skin tests were challenged...

Cite
Ben Fadhel N, Aroua F, Chadli Z, et al. Betalactam hypersensitivity: The importance of delabelling in primary care. Br J Clin Pharmacol. 2021;87(12):4619-4624doi: 10.1111/bcp.14879.
Ben Fadhel, N., Aroua, F., Chadli, Z., Ben Romdhane, H., Chaabane, A., Sahtout, M., Boughattas, N. A., Ben Fredj, N., & Aouam, K. (2021). Betalactam hypersensitivity: The importance of delabelling in primary care. British journal of clinical pharmacology, 87(12), 4619-4624. https://doi.org/10.1111/bcp.14879
Ben Fadhel, Najah, et al. "Betalactam hypersensitivity: The importance of delabelling in primary care." British journal of clinical pharmacology vol. 87,12 (2021): 4619-4624. doi: https://doi.org/10.1111/bcp.14879
Ben Fadhel N, Aroua F, Chadli Z, Ben Romdhane H, Chaabane A, Sahtout M, Boughattas NA, Ben Fredj N, Aouam K. Betalactam hypersensitivity: The importance of delabelling in primary care. Br J Clin Pharmacol. 2021 Dec;87(12):4619-4624. doi: 10.1111/bcp.14879. Epub 2021 May 14. PMID: 33899257.
Copy Download .nbib Format: NLM
Spinning disc photoreactor based visible-light-driven Ag/Ag.

Journal of environmental management

Zamani S, Rahimi MR, Ghaedi M.
PMID: 34896858
J Environ Manage. 2021 Dec 09;303:114216. doi: 10.1016/j.jenvman.2021.114216. Epub 2021 Dec 09.

The presence of antibiotics in waste and drinking water is causing increasing concern around the world, thereby an advanced sustainable technology needs to be developed to eliminate the antibiotics from water resources. Hence, an efficient spinning disc photoreactor (SDPR)...

Cite
Zamani S, Rahimi MR, Ghaedi M. Spinning disc photoreactor based visible-light-driven Ag/Ag. J Environ Manage. 2021;303:114216doi: 10.1016/j.jenvman.2021.114216.
Zamani, S., Rahimi, M. R., & Ghaedi, M. (2021). Spinning disc photoreactor based visible-light-driven Ag/Ag. Journal of environmental management, 303114216. https://doi.org/10.1016/j.jenvman.2021.114216
Zamani, S, et al. "Spinning disc photoreactor based visible-light-driven Ag/Ag." Journal of environmental management vol. 303 (2021): 114216. doi: https://doi.org/10.1016/j.jenvman.2021.114216
Zamani S, Rahimi MR, Ghaedi M. Spinning disc photoreactor based visible-light-driven Ag/Ag. J Environ Manage. 2021 Dec 09;303:114216. doi: 10.1016/j.jenvman.2021.114216. Epub 2021 Dec 09. PMID: 34896858.
Copy Download .nbib Format: NLM
Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends.

JAMA internal medicine

Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG.
PMID: 33871571
JAMA Intern Med. 2021 Jun 01;181(6):808-816. doi: 10.1001/jamainternmed.2021.1154.

IMPORTANCE: In May 2016, due to concerns of the risks outweighing the benefits, the US Food and Drug Administration (FDA) removed systemic quinolones' indications for acute, uncomplicated urinary tract infection (uUTI), acute sinusitis (AS), and acute exacerbation of chronic...

Cite
Tran PT, Antonelli PJ, Hincapie-Castillo JM, et al. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA Intern Med. 2021;181(6):808-816doi: 10.1001/jamainternmed.2021.1154.
Tran, P. T., Antonelli, P. J., Hincapie-Castillo, J. M., & Winterstein, A. G. (2021). Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA internal medicine, 181(6), 808-816. https://doi.org/10.1001/jamainternmed.2021.1154
Tran, Phuong T, et al. "Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends." JAMA internal medicine vol. 181,6 (2021): 808-816. doi: https://doi.org/10.1001/jamainternmed.2021.1154
Tran PT, Antonelli PJ, Hincapie-Castillo JM, Winterstein AG. Association of US Food and Drug Administration Removal of Indications for Use of Oral Quinolones With Prescribing Trends. JAMA Intern Med. 2021 Jun 01;181(6):808-816. doi: 10.1001/jamainternmed.2021.1154. PMID: 33871571; PMCID: PMC8056313.
Copy Download .nbib Format: NLM
Incorporation of amoxicillin-loaded microspheres in mineral trioxide aggregate cement: an .

Restorative dentistry & endodontics

Bohns FR, Leitune VCB, Garcia IM, Genari B, Dornelles NB, Guterres SS, Ogliari FA, de Melo MAS, Collares FM.
PMID: 33294415
Restor Dent Endod. 2020 Oct 07;45(4):e50. doi: 10.5395/rde.2020.45.e50. eCollection 2020 Nov.

OBJECTIVES: In this study, we investigated the potential of amoxicillin-loaded polymeric microspheres to be delivered to tooth root infection sites via a bioactive reparative cement.MATERIALS AND METHODS: Amoxicillin-loaded microspheres were synthesized by a spray-dray method and incorporated at 2.5%...

Cite
Bohns FR, Leitune VCB, Garcia IM, et al. Incorporation of amoxicillin-loaded microspheres in mineral trioxide aggregate cement: an . Restor Dent Endod. 2020;45(4):e50doi: 10.5395/rde.2020.45.e50.
Bohns, F. R., Leitune, V. C. B., Garcia, I. M., Genari, B., Dornelles, N. B., Guterres, S. S., Ogliari, F. A., de Melo, M. A. S., & Collares, F. M. (2020). Incorporation of amoxicillin-loaded microspheres in mineral trioxide aggregate cement: an . Restorative dentistry & endodontics, 45(4), e50. https://doi.org/10.5395/rde.2020.45.e50
Bohns, Fábio Rocha, et al. "Incorporation of amoxicillin-loaded microspheres in mineral trioxide aggregate cement: an ." Restorative dentistry & endodontics vol. 45,4 (2020): e50. doi: https://doi.org/10.5395/rde.2020.45.e50
Bohns FR, Leitune VCB, Garcia IM, Genari B, Dornelles NB, Guterres SS, Ogliari FA, de Melo MAS, Collares FM. Incorporation of amoxicillin-loaded microspheres in mineral trioxide aggregate cement: an . Restor Dent Endod. 2020 Oct 07;45(4):e50. doi: 10.5395/rde.2020.45.e50. eCollection 2020 Nov. PMID: 33294415; PMCID: PMC7691264.
Copy Download .nbib Format: NLM
Hepatic actinomycosis after total pancreatectomy: A case report.

International journal of surgery case reports

Sakaguchi T, Hashimoto D, Satoi S, Yamamoto T, Yamaki S, Sekimoto M.
PMID: 34330068
Int J Surg Case Rep. 2021 Aug;85:106212. doi: 10.1016/j.ijscr.2021.106212. Epub 2021 Jul 20.

INTRODUCTION AND IMPORTANCE: Hepatic actinomycosis (HA) is a rare infection mimicking a malignancy. HA after total pancreatectomy for a pancreatic tumor has not been reported.CASE PRESENTATION: A 70-year-old woman with a history of gastrectomy and sigmoidectomy for benign lesions,...

Cite
Sakaguchi T, Hashimoto D, Satoi S, et al. Hepatic actinomycosis after total pancreatectomy: A case report. Int J Surg Case Rep. 2021;85:106212doi: 10.1016/j.ijscr.2021.106212.
Sakaguchi, T., Hashimoto, D., Satoi, S., Yamamoto, T., Yamaki, S., & Sekimoto, M. (2021). Hepatic actinomycosis after total pancreatectomy: A case report. International journal of surgery case reports, 85106212. https://doi.org/10.1016/j.ijscr.2021.106212
Sakaguchi, Tatsuma, et al. "Hepatic actinomycosis after total pancreatectomy: A case report." International journal of surgery case reports vol. 85 (2021): 106212. doi: https://doi.org/10.1016/j.ijscr.2021.106212
Sakaguchi T, Hashimoto D, Satoi S, Yamamoto T, Yamaki S, Sekimoto M. Hepatic actinomycosis after total pancreatectomy: A case report. Int J Surg Case Rep. 2021 Aug;85:106212. doi: 10.1016/j.ijscr.2021.106212. Epub 2021 Jul 20. PMID: 34330068; PMCID: PMC8335620.
Copy Download .nbib Format: NLM
Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK.

The Journal of small animal practice

Fonseca JD, Mavrides DE, Graham PA, McHugh TD.
PMID: 34463359
J Small Anim Pract. 2021 Dec;62(12):1085-1091. doi: 10.1111/jsap.13406. Epub 2021 Aug 31.

OBJECTIVES: Bacterial urinary tract infections are a common diagnosis in small animal practice and antibiotics are often administered empirically. The aim of this study was to investigate the aetiology and antibiotic resistance of uropathogens in dogs and cats in...

Cite
Fonseca JD, Mavrides DE, Graham PA, et al. Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK. J Small Anim Pract. 2021;62(12):1085-1091doi: 10.1111/jsap.13406.
Fonseca, J. D., Mavrides, D. E., Graham, P. A., & McHugh, T. D. (2021). Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK. The Journal of small animal practice, 62(12), 1085-1091. https://doi.org/10.1111/jsap.13406
Fonseca, J D, et al. "Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK." The Journal of small animal practice vol. 62,12 (2021): 1085-1091. doi: https://doi.org/10.1111/jsap.13406
Fonseca JD, Mavrides DE, Graham PA, McHugh TD. Results of urinary bacterial cultures and antibiotic susceptibility testing of dogs and cats in the UK. J Small Anim Pract. 2021 Dec;62(12):1085-1091. doi: 10.1111/jsap.13406. Epub 2021 Aug 31. PMID: 34463359.
Copy Download .nbib Format: NLM
Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina.

Revista panamericana de salud publica = Pan American journal of public health

Boni S, Marin GH, Campaña L, Marin L, Corso A, Risso-Patron S, Gabriel F, Garay V, Limeres M.
PMID: 34322161
Rev Panam Salud Publica. 2021 Jul 26;45:e76. doi: 10.26633/RPSP.2021.76. eCollection 2021.

OBJECTIVE: To describe bacterial resistance and antimicrobial consumption ratio at the subnational level in Argentina during 2018, considering beta-lactams group as a case-study.METHODS: Antimicrobial consumption was expressed as defined daily doses (DDD)/1000 inhabitants. Resistance of RESULTS: The most widely...

Cite
Boni S, Marin GH, Campaña L, et al. Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina. Rev Panam Salud Publica. 2021;45:e76doi: 10.26633/RPSP.2021.76.
Boni, S., Marin, G. H., Campaña, L., Marin, L., Corso, A., Risso-Patron, S., Gabriel, F., Garay, V., & Limeres, M. (2021). Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina. Revista panamericana de salud publica = Pan American journal of public health, 45e76. https://doi.org/10.26633/RPSP.2021.76
Boni, Silvia, et al. "Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina." Revista panamericana de salud publica = Pan American journal of public health vol. 45 (2021): e76. doi: https://doi.org/10.26633/RPSP.2021.76
Boni S, Marin GH, Campaña L, Marin L, Corso A, Risso-Patron S, Gabriel F, Garay V, Limeres M. Disparities in antimicrobial consumption and resistance within a country: the case of beta-lactams in Argentina. Rev Panam Salud Publica. 2021 Jul 26;45:e76. doi: 10.26633/RPSP.2021.76. eCollection 2021. PMID: 34322161; PMCID: PMC8312146.
Copy Download .nbib Format: NLM
Showing 1861 to 1872 of 1876 entries